Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Fitzjohn

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Neuroscience Letters|January 30, 2002
Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1Robin A Morton, Frederick M Kuenzi, Stephen M Fitzjohn, et al.
Molecular Brain|July 9, 2009
A systematic investigation of the protein kinases involved in NMDA receptor-dependent LTD: evidence for a role of GSK-3 but not other serine/threonine kinasesStéphane Peineau, Céline S Nicolas, Zuner A Bortolotto, et al.
Neurochemistry International|May 9, 2012
Differences in kainate receptor involvement in hippocampal mossy fibre long-term potentiation depending on slice orientationJohn L Sherwood, Mascia Amici, Sheila L Dargan, et al.
Neuropharmacology|August 15, 2006
Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampusThomas E Bartlett, Neil J Bannister, Valerie J Collett, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 6, 2011
Study of novel selective mGlu2 agonist in the temporo-ammonic input to CA1 neurons reveals reduced mGlu2 receptor expression in a Wistar substrain with an anxiety-like phenotypeLaura Ceolin, Sriharsha Kantamneni, Gareth R I Barker, et al.
Neuropharmacology|April 2, 2013
Antagonists reversibly reverse chemical LTD induced by group I, group II and group III metabotropic glutamate receptorsDavid Lodge, Patrick Tidball, Marion S Mercier, et al.
Neuropharmacology|September 16, 2008
ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre functionSheila L Dargan, Vernon R J Clarke, Gregory M Alushin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 30, 2011
The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampusEva Hradetzky, Thomas M Sanderson, Tsz M Tsang, et al.
Neuron|January 31, 2012
The Jak/STAT pathway is involved in synaptic plasticityCéline S Nicolas, Stéphane Peineau, Mascia Amici, et al.
Neuropharmacology|January 10, 2016
In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu<sub>2/3</sub> receptor antagonistJeffrey M Witkin, Paul L Ornstein, Charles H Mitch, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Neuroscience Letters|January 30, 2002
Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1Robin A Morton, Frederick M Kuenzi, Stephen M Fitzjohn, et al.
Molecular Brain|July 9, 2009
A systematic investigation of the protein kinases involved in NMDA receptor-dependent LTD: evidence for a role of GSK-3 but not other serine/threonine kinasesStéphane Peineau, Céline S Nicolas, Zuner A Bortolotto, et al.
Neurochemistry International|May 9, 2012
Differences in kainate receptor involvement in hippocampal mossy fibre long-term potentiation depending on slice orientationJohn L Sherwood, Mascia Amici, Sheila L Dargan, et al.
Neuropharmacology|August 15, 2006
Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampusThomas E Bartlett, Neil J Bannister, Valerie J Collett, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 6, 2011
Study of novel selective mGlu2 agonist in the temporo-ammonic input to CA1 neurons reveals reduced mGlu2 receptor expression in a Wistar substrain with an anxiety-like phenotypeLaura Ceolin, Sriharsha Kantamneni, Gareth R I Barker, et al.
Neuropharmacology|April 2, 2013
Antagonists reversibly reverse chemical LTD induced by group I, group II and group III metabotropic glutamate receptorsDavid Lodge, Patrick Tidball, Marion S Mercier, et al.
Neuropharmacology|September 16, 2008
ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre functionSheila L Dargan, Vernon R J Clarke, Gregory M Alushin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 30, 2011
The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampusEva Hradetzky, Thomas M Sanderson, Tsz M Tsang, et al.
Neuron|January 31, 2012
The Jak/STAT pathway is involved in synaptic plasticityCéline S Nicolas, Stéphane Peineau, Mascia Amici, et al.
Neuropharmacology|January 10, 2016
In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu<sub>2/3</sub> receptor antagonistJeffrey M Witkin, Paul L Ornstein, Charles H Mitch, et al.
Pageof 4